메뉴 건너뛰기




Volumn 6, Issue 4, 2014, Pages 519-538

Corrigendum to A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis [EMBO Mol Med 6 (2014) 519-538] DOI 10.1002/emmm.201302734;A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis

Author keywords

AMPK direct activation; Androgen signaling inhibitors; de novo lipogenesis; MT 63 78; Prostate cancer

Indexed keywords

6,7 DIHYDRO 4 HYDROXY 3 (2' HYDROXY 1,1' BIPHENYL 4 YL) 6 OXOTHIENO[2,3 B]PYRIDINE 5 CARBONITRILE; ABIRATERONE; ACETIC ACID C 11; ANDROGEN; DEOXYGLUCOSE; ENZALUTAMIDE; GLUCOSE; HOE 33342; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ACTIVATOR; METFORMIN; MT 63 78; OLIGOMYCIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ENZYME ACTIVATOR;

EID: 84898601973     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.15252/emmm.201470070     Document Type: Erratum
Times cited : (171)

References (72)
  • 1
    • 58149186098 scopus 로고    scopus 로고
    • Pilot study of rapamycin in patients with hormone-refractory prostate cancer
    • Amato RJ, Jac J, Mohammad T, Saxena S (2008) Pilot study of rapamycin in patients with hormone-refractory prostate cancer. Clin Genitourin Cancer 6: 97-102
    • (2008) Clin Genitourin Cancer , vol.6 , pp. 97-102
    • Amato, R.J.1    Jac, J.2    Mohammad, T.3    Saxena, S.4
  • 2
    • 0347993103 scopus 로고    scopus 로고
    • Overexpression of diacylglycerol acyltransferase-1 reduces phospholipid synthesis, proliferation, and invasiveness in simian virus 40-transformed human lung fibroblasts
    • Bagnato C, Igal RA (2003) Overexpression of diacylglycerol acyltransferase-1 reduces phospholipid synthesis, proliferation, and invasiveness in simian virus 40-transformed human lung fibroblasts. J Biol Chem 278: 52203-52211
    • (2003) J Biol Chem , vol.278 , pp. 52203-52211
    • Bagnato, C.1    Igal, R.A.2
  • 6
    • 33845261493 scopus 로고
    • A rapid method of total lipid extraction and purification
    • Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911-917
    • (1959) Can J Biochem Physiol , vol.37 , pp. 911-917
    • Bligh, E.G.1    Dyer, W.J.2
  • 7
    • 33746592505 scopus 로고    scopus 로고
    • Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: response to Farooki and Schneider
    • Bowker SL, Majumdar SR, Veugelers P, Johnson JA (2006) Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: response to Farooki and Schneider. Diabetes Care 29: 1990-1991
    • (2006) Diabetes Care , vol.29 , pp. 1990-1991
    • Bowker, S.L.1    Majumdar, S.R.2    Veugelers, P.3    Johnson, J.A.4
  • 8
    • 78049312104 scopus 로고    scopus 로고
    • The lipogenic switch in cancer
    • In, Singh KK, Costello LC (eds), Springer, New York
    • Brusselmans K, Swinnen JV (2009). The lipogenic switch in cancer. In Mitochondria and Cancer, Singh KK, Costello LC (eds), pp 39-59. Springer, New York
    • (2009) Mitochondria and Cancer , pp. 39-59
    • Brusselmans, K.1    Swinnen, J.V.2
  • 10
    • 0141733088 scopus 로고    scopus 로고
    • Degradation of cyclin B is required for the onset of anaphase in Mammalian cells
    • Chang DC, Xu N, Luo KQ (2003) Degradation of cyclin B is required for the onset of anaphase in Mammalian cells. J Biol Chem 278: 37865-37873
    • (2003) J Biol Chem , vol.278 , pp. 37865-37873
    • Chang, D.C.1    Xu, N.2    Luo, K.Q.3
  • 11
    • 0025310576 scopus 로고
    • Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver
    • Clarke PR, Hardie DG (1990) Regulation of HMG-CoA reductase: identification of the site phosphorylated by the AMP-activated protein kinase in vitro and in intact rat liver. EMBO J 9: 2439-2446
    • (1990) EMBO J , vol.9 , pp. 2439-2446
    • Clarke, P.R.1    Hardie, D.G.2
  • 12
    • 0033145508 scopus 로고    scopus 로고
    • Temporal and spatial control of cyclin B1 destruction in metaphase
    • Clute P, Pines J (1999) Temporal and spatial control of cyclin B1 destruction in metaphase. Nat Cell Biol 1: 82-87
    • (1999) Nat Cell Biol , vol.1 , pp. 82-87
    • Clute, P.1    Pines, J.2
  • 14
    • 33744514139 scopus 로고    scopus 로고
    • Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
    • Cool B, Zinker B, Chiou W, Kifle L, Cao N, Perham M, Dickinson R, Adler A, Gagne G, Iyengar R et al (2006) Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab 3: 403-416
    • (2006) Cell Metab , vol.3 , pp. 403-416
    • Cool, B.1    Zinker, B.2    Chiou, W.3    Kifle, L.4    Cao, N.5    Perham, M.6    Dickinson, R.7    Adler, A.8    Gagne, G.9    Iyengar, R.10
  • 16
    • 1542615071 scopus 로고    scopus 로고
    • Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence
    • Ettinger SL, Sobel R, Whitmore TG, Akbari M, Bradley DR, Gleave ME, Nelson CC (2004) Dysregulation of sterol response element-binding proteins and downstream effectors in prostate cancer during progression to androgen independence. Cancer Res 64: 2212-2221
    • (2004) Cancer Res , vol.64 , pp. 2212-2221
    • Ettinger, S.L.1    Sobel, R.2    Whitmore, T.G.3    Akbari, M.4    Bradley, D.R.5    Gleave, M.E.6    Nelson, C.C.7
  • 19
    • 78649998496 scopus 로고    scopus 로고
    • Metabolic alterations and targeted therapies in prostate cancer
    • Flavin R, Zadra G, Loda M (2011) Metabolic alterations and targeted therapies in prostate cancer. J Pathol 223: 283-294
    • (2011) J Pathol , vol.223 , pp. 283-294
    • Flavin, R.1    Zadra, G.2    Loda, M.3
  • 20
    • 75349099919 scopus 로고    scopus 로고
    • Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer
    • Fogarty S, Hardie DG (2010) Development of protein kinase activators: AMPK as a target in metabolic disorders and cancer. Biochim Biophys Acta 1804: 581-591
    • (2010) Biochim Biophys Acta , vol.1804 , pp. 581-591
    • Fogarty, S.1    Hardie, D.G.2
  • 21
    • 74149083791 scopus 로고    scopus 로고
    • AMPK-independent down-regulation of cFLIP and sensitization to TRAIL-induced apoptosis by AMPK activators
    • Garcia-Garcia C, Fumarola C, Navaratnam N, Carling D, Lopez-Rivas A (2009) AMPK-independent down-regulation of cFLIP and sensitization to TRAIL-induced apoptosis by AMPK activators. Biochem Pharmacol 79: 853-863
    • (2009) Biochem Pharmacol , vol.79 , pp. 853-863
    • Garcia-Garcia, C.1    Fumarola, C.2    Navaratnam, N.3    Carling, D.4    Lopez-Rivas, A.5
  • 23
    • 84873547281 scopus 로고    scopus 로고
    • Metformin-an adjunct antineoplastic therapy-divergently modulates tumor metabolism and proliferation, interfering with early response prediction by 18F-FDG PET imaging
    • Habibollahi P, van den Berg NS, Kuruppu D, Loda M, Mahmood U (2013) Metformin-an adjunct antineoplastic therapy-divergently modulates tumor metabolism and proliferation, interfering with early response prediction by 18F-FDG PET imaging. J Nucl Med 54: 252-258
    • (2013) J Nucl Med , vol.54 , pp. 252-258
    • Habibollahi, P.1    van den Berg, N.S.2    Kuruppu, D.3    Loda, M.4    Mahmood, U.5
  • 24
    • 33847072201 scopus 로고    scopus 로고
    • AMP-activated protein kinase as a drug target
    • Hardie DG (2007) AMP-activated protein kinase as a drug target. Annu Rev Pharmacol Toxicol 47: 185-210
    • (2007) Annu Rev Pharmacol Toxicol , vol.47 , pp. 185-210
    • Hardie, D.G.1
  • 25
    • 0031007065 scopus 로고    scopus 로고
    • The AMP-activated protein kinase-fuel gauge of the mammalian cell?
    • Hardie DG, Carling D (1997) The AMP-activated protein kinase-fuel gauge of the mammalian cell? Eur J Biochem 246: 259-273
    • (1997) Eur J Biochem , vol.246 , pp. 259-273
    • Hardie, D.G.1    Carling, D.2
  • 28
    • 80755169423 scopus 로고    scopus 로고
    • New and emerging agents for the treatment of castration-resistant prostate cancer
    • Higano CS, Crawford ED (2011) New and emerging agents for the treatment of castration-resistant prostate cancer. Urol Oncol 29: S1-S8
    • (2011) Urol Oncol , vol.29
    • Higano, C.S.1    Crawford, E.D.2
  • 29
    • 34250891313 scopus 로고    scopus 로고
    • AMP-activated protein kinase: a universal regulator of autophagy?
    • Hoyer-Hansen M, Jaattela M (2007) AMP-activated protein kinase: a universal regulator of autophagy? Autophagy 3: 381-383
    • (2007) Autophagy , vol.3 , pp. 381-383
    • Hoyer-Hansen, M.1    Jaattela, M.2
  • 31
    • 48549091164 scopus 로고    scopus 로고
    • Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver
    • Jiang W, Zhu Z, Thompson HJ (2008) Dietary energy restriction modulates the activity of AMP-activated protein kinase, Akt, and mammalian target of rapamycin in mammary carcinomas, mammary gland, and liver. Cancer Res 68: 5492-5499
    • (2008) Cancer Res , vol.68 , pp. 5492-5499
    • Jiang, W.1    Zhu, Z.2    Thompson, H.J.3
  • 34
    • 84859778293 scopus 로고    scopus 로고
    • mTOR signaling in growth control and disease
    • Laplante M, Sabatini DM (2012) mTOR signaling in growth control and disease. Cell 149: 274-293
    • (2012) Cell , vol.149 , pp. 274-293
    • Laplante, M.1    Sabatini, D.M.2
  • 36
    • 80655125020 scopus 로고    scopus 로고
    • Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator
    • Lee KH, Hsu EC, Guh JH, Yang HC, Wang D, Kulp SK, Shapiro CL, Chen CS (2011) Targeting energy metabolic and oncogenic signaling pathways in triple-negative breast cancer by a novel adenosine monophosphate-activated protein kinase (AMPK) activator. J Biol Chem 286: 39247-39258
    • (2011) J Biol Chem , vol.286 , pp. 39247-39258
    • Lee, K.H.1    Hsu, E.C.2    Guh, J.H.3    Yang, H.C.4    Wang, D.5    Kulp, S.K.6    Shapiro, C.L.7    Chen, C.S.8
  • 37
    • 73449094929 scopus 로고    scopus 로고
    • A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival
    • Li H, Stampfer MJ, Mucci L, Rifai N, Qiu W, Kurth T, Ma J (2010) A 25-year prospective study of plasma adiponectin and leptin concentrations and prostate cancer risk and survival. Clin Chem 56: 34-43
    • (2010) Clin Chem , vol.56 , pp. 34-43
    • Li, H.1    Stampfer, M.J.2    Mucci, L.3    Rifai, N.4    Qiu, W.5    Kurth, T.6    Ma, J.7
  • 39
    • 27844506524 scopus 로고    scopus 로고
    • Akt-regulated pathways in prostate cancer
    • Majumder PK, Sellers WR (2005) Akt-regulated pathways in prostate cancer. Oncogene 24: 7465-7474
    • (2005) Oncogene , vol.24 , pp. 7465-7474
    • Majumder, P.K.1    Sellers, W.R.2
  • 40
    • 39749104209 scopus 로고    scopus 로고
    • Mechanisms linking physical activity with cancer
    • McTiernan A (2008) Mechanisms linking physical activity with cancer. Nat Rev Cancer 8: 205-211
    • (2008) Nat Rev Cancer , vol.8 , pp. 205-211
    • McTiernan, A.1
  • 41
    • 34748912615 scopus 로고    scopus 로고
    • Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
    • Menendez JA, Lupu R (2007) Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 7: 763-777
    • (2007) Nat Rev Cancer , vol.7 , pp. 763-777
    • Menendez, J.A.1    Lupu, R.2
  • 43
    • 46749127292 scopus 로고    scopus 로고
    • A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism
    • Moreno D, Knecht E, Viollet B, Sanz P (2008) A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism. FEBS Lett 582: 2650-2654
    • (2008) FEBS Lett , vol.582 , pp. 2650-2654
    • Moreno, D.1    Knecht, E.2    Viollet, B.3    Sanz, P.4
  • 48
    • 77949653043 scopus 로고    scopus 로고
    • Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation
    • Pradelli LA, Beneteau M, Chauvin C, Jacquin MA, Marchetti S, Munoz-Pinedo C, Auberger P, Pende M, Ricci JE (2010) Glycolysis inhibition sensitizes tumor cells to death receptors-induced apoptosis by AMP kinase activation leading to Mcl-1 block in translation. Oncogene 29: 1641-1652
    • (2010) Oncogene , vol.29 , pp. 1641-1652
    • Pradelli, L.A.1    Beneteau, M.2    Chauvin, C.3    Jacquin, M.A.4    Marchetti, S.5    Munoz-Pinedo, C.6    Auberger, P.7    Pende, M.8    Ricci, J.E.9
  • 49
    • 84860523917 scopus 로고    scopus 로고
    • Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100
    • Richards J, Lim AC, Hay CW, Taylor AE, Wingate A, Nowakowska K, Pezaro C, Carreira S, Goodall J, Arlt W et al (2012) Interactions of abiraterone, eplerenone, and prednisolone with wild-type and mutant androgen receptor: a rationale for increasing abiraterone exposure or combining with MDV3100. Cancer Res 72: 2176-2182
    • (2012) Cancer Res , vol.72 , pp. 2176-2182
    • Richards, J.1    Lim, A.C.2    Hay, C.W.3    Taylor, A.E.4    Wingate, A.5    Nowakowska, K.6    Pezaro, C.7    Carreira, S.8    Goodall, J.9    Arlt, W.10
  • 51
    • 0034737439 scopus 로고    scopus 로고
    • Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139
    • Rogakou EP, Nieves-Neira W, Boon C, Pommier Y, Bonner WM (2000) Initiation of DNA fragmentation during apoptosis induces phosphorylation of H2AX histone at serine 139. J Biol Chem 275: 9390-9395
    • (2000) J Biol Chem , vol.275 , pp. 9390-9395
    • Rogakou, E.P.1    Nieves-Neira, W.2    Boon, C.3    Pommier, Y.4    Bonner, W.M.5
  • 53
    • 84863837081 scopus 로고    scopus 로고
    • Lipid metabolism in cancer
    • Santos CR, Schulze A (2012) Lipid metabolism in cancer. FEBS J 279: 2610-2623
    • (2012) FEBS J , vol.279 , pp. 2610-2623
    • Santos, C.R.1    Schulze, A.2
  • 54
    • 67749111502 scopus 로고    scopus 로고
    • The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
    • Shackelford DB, Shaw RJ (2009) The LKB1-AMPK pathway: metabolism and growth control in tumour suppression. Nat Rev Cancer 9: 563-575
    • (2009) Nat Rev Cancer , vol.9 , pp. 563-575
    • Shackelford, D.B.1    Shaw, R.J.2
  • 55
    • 63849149937 scopus 로고    scopus 로고
    • LKB1 and AMP-activated protein kinase control of mTOR signalling and growth
    • Shaw RJ (2009) LKB1 and AMP-activated protein kinase control of mTOR signalling and growth. Acta Physiol 196: 65-80
    • (2009) Acta Physiol , vol.196 , pp. 65-80
    • Shaw, R.J.1
  • 56
    • 67650914230 scopus 로고    scopus 로고
    • AMPK in health and disease
    • Steinberg GR, Kemp BE (2009) AMPK in health and disease. Physiol Rev 89: 1025-1078
    • (2009) Physiol Rev , vol.89 , pp. 1025-1078
    • Steinberg, G.R.1    Kemp, B.E.2
  • 58
    • 0030666828 scopus 로고    scopus 로고
    • Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins
    • Swinnen JV, Ulrix W, Heyns W, Verhoeven G (1997) Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc Natl Acad Sci USA 94: 12975-12980
    • (1997) Proc Natl Acad Sci USA , vol.94 , pp. 12975-12980
    • Swinnen, J.V.1    Ulrix, W.2    Heyns, W.3    Verhoeven, G.4
  • 59
    • 84865115634 scopus 로고    scopus 로고
    • AMPK regulates mitotic spindle orientation through phosphorylation of myosin regulatory light chain
    • Thaiparambil JT, Eggers CM, Marcus AI (2012) AMPK regulates mitotic spindle orientation through phosphorylation of myosin regulatory light chain. Mol Cell Biol 32: 3203-3217
    • (2012) Mol Cell Biol , vol.32 , pp. 3203-3217
    • Thaiparambil, J.T.1    Eggers, C.M.2    Marcus, A.I.3
  • 60
    • 0036469122 scopus 로고    scopus 로고
    • Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells
    • Van de Sande T, De Schrijver E, Heyns W, Verhoeven G, Swinnen JV (2002) Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res 62: 642-646
    • (2002) Cancer Res , vol.62 , pp. 642-646
    • Van de Sande, T.1    De Schrijver, E.2    Heyns, W.3    Verhoeven, G.4    Swinnen, J.V.5
  • 61
    • 66249108601 scopus 로고    scopus 로고
    • Understanding the Warburg effect: the metabolic requirements of cell proliferation
    • Vander Heiden MG, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324: 1029-1033
    • (2009) Science , vol.324 , pp. 1029-1033
    • Vander Heiden, M.G.1    Cantley, L.C.2    Thompson, C.B.3
  • 62
    • 38949208937 scopus 로고    scopus 로고
    • 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer
    • Vavere AL, Kridel SJ, Wheeler FB, Lewis JS (2008) 1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J Nucl Med 49: 327-334
    • (2008) J Nucl Med , vol.49 , pp. 327-334
    • Vavere, A.L.1    Kridel, S.J.2    Wheeler, F.B.3    Lewis, J.S.4
  • 65
    • 68449094064 scopus 로고    scopus 로고
    • The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis
    • Vazquez-Martin A, Oliveras-Ferraros C, Menendez JA (2009a) The active form of the metabolic sensor: AMP-activated protein kinase (AMPK) directly binds the mitotic apparatus and travels from centrosomes to the spindle midzone during mitosis and cytokinesis. Cell Cycle 8: 2385-2398
    • (2009) Cell Cycle , vol.8 , pp. 2385-2398
    • Vazquez-Martin, A.1    Oliveras-Ferraros, C.2    Menendez, J.A.3
  • 68
    • 3543025724 scopus 로고    scopus 로고
    • AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms
    • Xiang X, Saha AK, Wen R, Ruderman NB, Luo Z (2004) AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms. Biochem Biophys Res Commun 321: 161-167
    • (2004) Biochem Biophys Res Commun , vol.321 , pp. 161-167
    • Xiang, X.1    Saha, A.K.2    Wen, R.3    Ruderman, N.B.4    Luo, Z.5
  • 69
    • 84901827161 scopus 로고    scopus 로고
    • Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis
    • doi: 10.1038/onc.2013.235.
    • Yuan X, Cai C, Chen S, Chen S, Yu Z, Balk SP (2013) Androgen receptor functions in castration-resistant prostate cancer and mechanisms of resistance to new agents targeting the androgen axis. Oncogene doi: 10.1038/onc.2013.235.
    • (2013) Oncogene
    • Yuan, X.1    Cai, C.2    Chen, S.3    Chen, S.4    Yu, Z.5    Balk, S.P.6
  • 71
    • 61449113987 scopus 로고    scopus 로고
    • The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase
    • Zakikhani M, Dowling RJ, Sonenberg N, Pollak MN (2008) The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase. Cancer Prev Res 1: 369-375
    • (2008) Cancer Prev Res , vol.1 , pp. 369-375
    • Zakikhani, M.1    Dowling, R.J.2    Sonenberg, N.3    Pollak, M.N.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.